Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00833755 · ClinicalTrials.gov registry record · NA
Effect of Ketamine on Opioid-Induced Hyperalgesia
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 79
- Enrollment target
NCT00833755: Completed NA study, sponsored by Massachusetts General Hospital.
NCT00833755 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 79 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00833755, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 79 participants
- Enrollment target
Study Summary
The purpose of this study is to compare pain threshold, pain tolerance, and wind up, as measured by QST, before and after a single dose of ketamine infusion under two clinical conditions: chronic pain patients on opioid therapy and chronic pain patients without opioid therapy.
Interventions
- DRUG Ketamine
- DRUG Placebos
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 2008-09 |
| Est. Completion | 2016-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00833755
The ClinicalTrials.gov registry entry for NCT00833755 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 79 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ketamine is the first listed.
NCT00833755 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00833755 about?
NCT00833755 is a clinical study titled "Effect of Ketamine on Opioid-Induced Hyperalgesia". The purpose of this study is to compare pain threshold, pain tolerance, and wind up, as measured by QST, before and after a single dose of ketamine infusion under two clinical conditions: chronic pain patients on opioid therapy and chronic pain patients without opioid therapy.
What is the current status of trial NCT00833755?
This trial is currently completed. It is a NA study. The enrollment target is 79 participants. The study started on 2008-09. Estimated completion is 2016-04.
What interventions are being tested in trial NCT00833755?
The interventions under investigation include: Ketamine (DRUG), Placebos (DRUG).
Who is sponsoring clinical trial NCT00833755?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.